[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP0181075B1 - Petri dish for cultivating bacteria and a method of testing drug susceptibility - Google Patents

Petri dish for cultivating bacteria and a method of testing drug susceptibility Download PDF

Info

Publication number
EP0181075B1
EP0181075B1 EP85306742A EP85306742A EP0181075B1 EP 0181075 B1 EP0181075 B1 EP 0181075B1 EP 85306742 A EP85306742 A EP 85306742A EP 85306742 A EP85306742 A EP 85306742A EP 0181075 B1 EP0181075 B1 EP 0181075B1
Authority
EP
European Patent Office
Prior art keywords
petri dish
sheet
media
bacteria
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP85306742A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0181075A1 (en
Inventor
Kenzi Asano
Kazuyuki Sugahara
Tetsuya Takakura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of EP0181075A1 publication Critical patent/EP0181075A1/en
Application granted granted Critical
Publication of EP0181075B1 publication Critical patent/EP0181075B1/en
Expired legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/10—Petri dish

Definitions

  • This invention relates to petri dishes for cultivating bacteria.
  • the dishes may be used for such purposes as isolation of bacteria, enrichment culture, and drug susceptibility testing.
  • the invention also rotates to a method of testing drug susceptibility of bacteria which may be isolated from a clinical specimen etc. or purely cultured after their isolation, using the Petri dish of the invention.
  • the media suitable for the growth of the bacteria are varied, depending upon the kind of bacteria, however. So when screening pathogenic bacteria, a preparation of the medium adequate each of the possible bacteria is needed.
  • the bacteria which may be found in a blood specimen are specified to be staphylococcus, streptococcus, pneumococcus, enterococcus, haemophylus, salmonella, escherichia coli, pseudomonas aeruginosa, anaerobic bacterium, campylobacter, brucella, etc. and usually in order to isolate any of these bacteria, there is a necessity of preparing each of blood agar medium, chocolate agar medium, isolation medium for anaerobic bacterium, medium for enrichment, etc.
  • salmonella, dysentery bacillus, pathogenic coli, yersinia enterocolitica, klebsiella oxytoca, vibrio, staphylococcus, bacillus cereus, etc. may be detected from the feces and as medium for any of these bacteria, a preparation of each of BTB lactose agar medium, DHL agar medium, SS agar medium, isolation medium for anaerobic bacterium, medium for enrichment, etc. is needed.
  • each operation has to be performed as aseptically as possible.
  • a separate pouring of one medium per one Petri dish increases the number of Petri dishes necessary for one specimen, so it is substantially impossible to prepare adequately the necessary amount of media in the hospital's test room where the number of specimens and the kind of bacteria being handled are not constant. For this reason, it is common to make or purchase the estimated amount necessary for a predetermined period and consume these gradually while storing the stock of unused dishes in a refrigerator.
  • the dishes have a lid simply fitting around the container for the media, so there is a problem of humidity and various bacteria contaminating the media.
  • a drying operation is indispensable, but media which are in a deaired state during storage or at the time of being purchased, dissolve oxygen from the air during such a drying operation. So, if anaerobic bacteria are handled, the filled dishes need to be placed in an anaerobic chamber after drying.
  • the kind and concentration of the drug effective to the bacteria depend on the kind of the bacteria and the recent spread of the chemotherapy triggers an appearance of bacterial stock (resistant bacteria) which show a tolerance to a drug which was previously effective so that if any bacterium causing the infectious disease is determined, it is substantially impossible to assume that a drug will be effective. For this reason, for clinically adequate and reasonable therapy, it ought not to be forgotten that the drug susceptibility test is one of the important items among the bacterial items to be investigated.
  • dilution methods As a method of testing the drug susceptibility of the bacteria, dilution methods, diffusion methods, and a nephelometry method are available for use.
  • An agar plate dilution method using agar medium and a broth dilution method are both dilution methods.
  • a sensitive tablet method, a sensitivity disk method, a decantation plate method, and a vertical diffusion method are diffusion methods.
  • the agar plate dilution method and the sensitivity disk method are the chief methods used.
  • the sensitivity disk method being easy to operate and capable of testing a plurality of drugs and concentration, simply by one Petri dish, is widely utilized, the thickness, inclination, or kind of medium on which the disk is put can easily make a fluctuation in the magnitude of the inhibition circle which occurs. The test is thus apt to lack reproducibility.
  • a 3-concentration disk method in which a judgement is made on the basis not of the magnitude of the inhibition circle but only of its existence, is sometimes used.
  • the setup width of the drug concentration is larger, so such a method is not suitable for measuring minimum inhibitory concentration (MIC) of the bacteria to be tested.
  • the agar plate dilution method uses media which have a drug of a predetermined concentration incorporated therein in advance. This is better is reproducibility and can freely set the concentration of the drug. Since it needs one medium per one drug or concentration setup, having to perform the inoculation operation for every one medium, it is complicated.
  • the conventional drug susceptibility test the purpose of which is to decide a method of treatment, regards the drug concentration at which the growth of all the bacteria is inhibited as important, but does not pay attention to the magnitude of the drug susceptibility-of the stock of bacteria to be tested-at each drug concentration.
  • the present invention intends to solve the problems possessed by the foregoing conventional petri dish for cultivating the bacteria, i.e. the forced necessity of executing complicated operations in order to prepare the media.
  • Forms of the invention address the difficulty that the inoculation operation can only inoculate the bacteria into one medium in one operation.
  • a further aim of the present invention is to solve the problem that the media get dry or are contaminated by humidity and various bacteria during storage and in transit.
  • a still further aim of forms of the present invention is to solve the problems of the complicated operations needed for the media preparation and the inoculation in the above-mentioned conventional test method while avoiding the lower reproducibility of the sensitivity disk method.
  • the present invention provides a Petri dish for cultivating bacteria characterised in that the mouth at the upper edge of the Petri dish proper is covered with at least one sheet and at least one small aperture for filling the dish is provided in the bottom of said Petri dish.
  • the Petri dish of the invention is filled by pouring in through the small aperture in the bottom of the dish while the dish is inverted.
  • the small aperture may be provided with a detachable sealing lid.
  • the sheet may be a sheet (hereinafter referred to as the pervious sheet) pervious to the component(s) of the medium or media with which the Petri dish is filled and may be able to hold the bacteria. It is also possible for the sheet to be a sheet (hereinafter referred to as the impervious sheet) impervious to the component of the media, in which case the sheet needs to be able to cover and be detachable from the Petri dish proper.
  • the impervious sheet may also be impervious to water and oxygen. It is further acceptable to cover the outside of a pervious sheet with a detachable impervious sheet.
  • Petri dish in accordance with this invention is subdivided by partitions, the height of which extends between the bottom of said Petri dish and the said sheet which covers the mouth of the dish.
  • the invention provides a method of testing drug susceptibility, utilising this sub-divided (i.e. fractionized) form of dish.
  • the method of the present invention using the fractionized Petri dish with a pervious sheet as the cultivation surface, separates media which are different in kind from each other.
  • the media may differ from each other in the kind of drug which they contain or the media may contain drugs which are of the same in kind, but differ in the concentration from each other in each fraction, into which the bacteria are inoculated, thereby solving the problems of the above-mentioned conventional methods.
  • Preparation of such a Petri dish can be easily and aseptically performed by pouring in each of its media,' separately from the others, through the small aperture(s) provided on the bottom of the Petri dish.
  • the unification of the height of the cultivation surface which is accomplished by the sheet covering the mouth of the dish, enables the entire region of the fractionized medium to be inoculated with the bacteria in one operation.
  • the medium When using an impervious sheet, the medium does not get dry. Humidity and various bacteria do not contaminate the medium during storage or in transit. Since the medium is sealed from direct contact with the air, its deterioration due to oxidation is inhibited. Also at the time of the inoculation operation, removal of the impervious sheet exposes a cultivation surface which is all in the same plane even if the medium is fractionized. This enables inoculating bacteria into the entire region of such a fractionized medium in one operation.
  • the above-mentioned pervious sheet (2) needs to possess holes or pores through which component(s) of the medium filled between the Petri dish proper (1) and the pervious sheet (2) can percolate to the surface of the previous sheet (2).
  • the material of the pervious sheet may be a porous film or a porous rubber film.
  • the medium with which the Petri dish is filled contains solidifying agent such as agar, materials such as cloth and paper which have wider pores may be applicable. If a synthetic resin film which is hydrophobic is used, a hydrophilic treatment should be applied to it in advance.
  • the strength of the pervious sheet (2) the requirement is to achieve a flat surface of the medium, when the Petri dish is filled therewith. If the material needs any reinforcement, synthetic fiber, etc. can act in such a role.
  • the small aperture (4) on the bottom (3) of the Petri dish preferably needs to be provided with a detachable sealing lid (6). Necessity for this is sometimes reduced almost to nil in the case where the medium with which the Petri dish is filled contains a solidifying agent such as agar. Sealing the aperture (6) preserves a sterile state of the interior of the Petri dish (1).
  • the (5) is a Petri dish lid, made of the plastic or glass and preferably transparent.
  • the internal periphery of this is equipped with an annular projection (7).
  • This projection (7) is provided to form a clearance between the pervious sheet (2) and the Petri dish lid (5), when the Petri dish lid (5) is fitted over the Petri dish proper (1), whereby a colony of the bacteria which is grown on the surface of the pervious sheet (2) is prevented from sticking to the internal face of the Petri dish lid (5).
  • the projection (7) also serves to keep adequate airtighness with regard to the outside.
  • the position of the above-mentioned projection (7) is not necessarily limited to the internal periphery of the Petri dish lid (5). It may acceptably be located on the periphery of the pervious sheet (2) or the periphery at the upper edge of the Petri dish proper (1).
  • the above-mentioned Petri dish proper (1) can be provided with partitions (8) the height of which matches the distance between the bottom (3) of the Petri dish and the pervious sheet (2). In that case, all the sub-sections (9) of the dish created by the partitions (8) are required to be accessible through one or more small apertures (4).
  • the impervious sheet (11) may have any thickness and is required to be impervious to water and oxygen.
  • a preferred material is a synthetic resin membrane or film, higher in oxygen gas barrier properties, such as polyacrylonitrile nylon, polymethacrylonitrile, ethylene vinyl alcohol polymer, polyvinylidene chloride, polyethylene terephthalate or polyvinyl chloride.
  • Other materials, on which are laminated the above-mentioned resin of higher oxygen gas barrier properties or metallic foil such as aluminium foil, may meet the requirements to fulfil the relevant purpose.
  • the sheet (11) may be reinforced by insertion of a flat reinforcing member into a clearance between the impervious sheet (11) and the Petri dish lid (5) until the medium has solidified.
  • the small aperture (4) on the bottom (3) of the Petri dish is detachably equipped with a sealing lid (6), the preferred condition is realised, maintaining the aseptic state of the inside of the Petri dish proper (1) which has previously been sterilized.
  • the entire Petri dish can be kept in the aseptic state, similarly to the conventional Petri dish.
  • the bottom (3) of the Petri dish can be made such that the bottom (3) slopes from the periphery of the Petri dish proper (1) to the small aperture (4). In this case when pouring the media into the Petri dish, it is possible to fill the Petri dish with the media without giving rise to foam.
  • FIG 11 illustrates an embodiment wherein partitions (8) divide the Petri dish proper (1) into four sub-sections.
  • Each of the sub-sections (9) is provided with a respective small aperture (4), whereby as the separate pouring of media into each sub-section (9) is completed, its small aperture (4) can be sealed by a sealing lid (6). This is advantageous in minimizing the risk of contamination by bacteria.
  • FIGs 12 to 15 illustrate an embodiment using both the foregoing pervious sheet (2) and impervious sheet (11).
  • the mouth at the upper edge of the Petri dish proper (1) is covered with the pervious sheet (2), which is in turn detachably covered with the impervious sheet (11).
  • the Petri dish for cultivating the bacteria according to the present invention can be utilized for all kinds of agar media, other than the liquid or semifluid media; although it is even possible to use these as mentioned below.
  • This embodiment uses a Petri dish such as shown in Figures 4 to 6, i.e., a Petri dish sub-divided into four, wherein the mouth at the upper edge of the Petri dish proper (1) is covered with the pervious sheet (2).
  • the Petri dish proper (1) is provided with the partitions (8) the height of which matches the distance between the bottom (3) of the Petri dish and the pervious sheet (2).
  • the bottom (3) of the Petri dish is provided with an aforesaid small aperture (4) which communicates with all the sub-sections (9) produced by the above-mentioned partitions (8).
  • the small aperture (4) is equipped with a sealing lid (6).
  • porous polyvinylidene fluoride membrane (bore: 0.45 ⁇ m) is used.
  • Müller-Hinton agar medium as the medium, a fixed amount of diluted solution of each drug is added to the medium in order to obtain such a drug concentration as shown in List (1 ).
  • One sub-section (9) of each Petri dish is left as a control, and media with respective different drug concentrations are poured separately into the three other sub-sections (9) and solidified therein. (Since this provides 3 media per Petri dish, 12 different media need four Petri dishes).
  • Plain Müller-Hinton medium is separately poured into the sub-sections (9) used as controls.
  • the pus from the patient is inoculated by a different method, using a spiral plater (made by Spiral System Instruments, U.S.A).
  • This spiral plater which is an inoculating device incorporated into an automatic system for measuring the number of live bacteria, being developed and evaluated by FDA in U.S.A. performs the inoculation process in such a way that the material to be tested is spirally smeared on the medium, while the material to be tested is given a density gradient which is subjectto the distance from the center of the medium.
  • the material to be tested is inoculated by being smeared on the pervious sheet (2) at the predetermined density gradient, a simple completion of measuring the number of isolated colonies per a fixed area will enable the total number of live bacteria contained in the unit quantity of the material to be tested to be counted out, and, furthermore, of course, in addition to the drug susceptibility value in accordance with the conventional standard, patterns of the sensitivity of the bacteria causing the disease to each drug at its various kinds of concentration stages to be easily and rapidly obtained.
  • staphylococcus aureus is isolated at the rate of 2.8x10 4 CFU/ml.
  • Petri dish proper (1) With the medium without opening the Petri dish lid (5).
  • the manner of filling the dish is that, while the Petri dish lid (5) is in place, the Petri dish is turned upside down, and the medium or media are poured in, separately from each other if more than one, through the small aperture (4) in the bottom (3) of the Petri dish. Forthis reason, since the Petri dish lid (5) is not opened when pouring the media, the danger of the media being contaminated by various bacteria is reduced in comparison with the conventional type of Petri dish.
  • the media When the pervious sheet (2) is used, the media is solidified on the previous sheet (2) which is a bottom surface while the dish is upside down.
  • the pervious sheet (2) acts as the cultivation surface when the media are subsequently used for inoculation and cultivation. Solidification of the medium does not need a flat table as is needed conventionally, because vibration during the solidification does not cause turbulence on the eventual working surface of the medium.
  • the impervious sheet (11) When using the impervious sheet (11), the impervious sheet (11) is removed when the medium is to be used for inoculation and cultivation and the foregoing effect may be also produced.
  • the level of the cultivation surface of the media with which each fraction is filled is unified by the aforementioned pervious sheet (2) or impervious sheet (11). Inoculation by an automatic inoculating device such as the spiral plater-which has difficulty in operating with a conventional partitioned Petri dish due to the difference in level between the media and the partitions (8)-becomes possible. Also in the case of manual inoculation, it is possible to inoculate bacteria into a majority of media in one operation.
  • the Petri dish with the aforementioned pervious sheet since the shape of the medium with which the Petri dish proper (1) is filled is restricted by the Petri dish proper (1) and the pervious sheet (2), it is possible to fill the dish with a liquid medium, provided that a resin of higher water absorbency comprising such materials as polyacrylic soda, starch polyacrylate or PVA, or a solidifying agent comprising such materials as alginic acid of natural origin or carboxy methyl cellulose, are sealed in the Petri dish proper (1). Thereby it is made easy to carry out a preparation of the medium containing the drug, which conventionally needed complicated operations. In addition, if each of the sub-sections (9) of the Petri dish proper (1) is filled with media which differ from each other in the concentration of the drug which they contain the resulting arrangement is convenient for carrying out a drug susceptibility test.
  • the media are sealed between the impervious sheet (11) and the Petri dish proper (1) during storage or in transit after filling the Petri dish with the media.
  • the media do not come into contact with the air, consequently preventing their drying and deterioration due to oxidation, wetting of the cultivation surface due to humidity, and contamination by various bacteria, during storage.
  • This possibility that the media poured into the inside are stored in a state where they are screened from the air can be utilised when cultivating anaerobic bacteria. If the media are deaerated in advance by pressure reduction, boiling, ultrasonic treatment, etc. before being poured into the dish, storage while screened from the air provides a medium which has less dissolved oxygen than a conventional medium.
  • the petri dish for cultivating the bacteria according to the present invention can also be used for the screening of pathogenic bacteria, using several individual dishes with appropriate media on their sub-divisions.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Clinical Laboratory Science (AREA)
  • Sustainable Development (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP85306742A 1984-10-09 1985-09-23 Petri dish for cultivating bacteria and a method of testing drug susceptibility Expired EP0181075B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP212163/84 1984-10-09
JP59212163A JPS6192561A (ja) 1984-10-09 1984-10-09 細菌培養用シヤ−レ

Publications (2)

Publication Number Publication Date
EP0181075A1 EP0181075A1 (en) 1986-05-14
EP0181075B1 true EP0181075B1 (en) 1988-11-02

Family

ID=16617946

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85306742A Expired EP0181075B1 (en) 1984-10-09 1985-09-23 Petri dish for cultivating bacteria and a method of testing drug susceptibility

Country Status (8)

Country Link
US (2) US4775628A (ja)
EP (1) EP0181075B1 (ja)
JP (1) JPS6192561A (ja)
KR (1) KR890003945B1 (ja)
CN (1) CN85106361B (ja)
AU (1) AU567225B2 (ja)
CA (1) CA1252375A (ja)
DE (1) DE3565997D1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202262A (en) * 1984-01-31 1993-04-13 Millipore Corporation Apparatus for microbiological testing of liquids
FI72741C (fi) * 1986-02-21 1987-07-10 Valio Meijerien Foerfarande foer bestaemning mikrobkoncentrationer medelst en smaeltagarmetod samt daeri anvaenda skaolar.
JPH0640813B2 (ja) * 1988-02-17 1994-06-01 ダイキン工業株式会社 培養器
GB8905001D0 (en) * 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
US5190879A (en) * 1990-05-08 1993-03-02 Bowolfe, Inc. Controlled environment animal isolation systems
WO1992007061A1 (de) * 1990-10-17 1992-04-30 Fritz Reulecke Behälter für kulturmedien und verwendung des behälters
CH686521A5 (fr) * 1991-05-23 1996-04-15 Eduard Dr Engelbrecht Support pour milieux de culture compartimente et milieux de culture électifs complémentaires.
US5463223A (en) * 1994-01-24 1995-10-31 Patwong Technologies, Inc. Disposable all purpose micro sample holder
US5593891A (en) * 1994-11-10 1997-01-14 Banes; Albert J. Culture plate with splash guard
US6001586A (en) * 1996-03-29 1999-12-14 Genencor International, Inc. Compartmentalization method for screening microorganisms
JP2003225083A (ja) * 2002-02-05 2003-08-12 Sony Corp 円盤状培養媒体
US7384599B2 (en) * 2003-01-30 2008-06-10 Randy Brewer Apparatus for drug testing
US20050239200A1 (en) * 2004-04-23 2005-10-27 Beckwith Scott W Devices for culturing anaerobic microorganisms and methods of using the same
JP4740584B2 (ja) * 2004-12-14 2011-08-03 オリンパス株式会社 観察装置
JP4810093B2 (ja) * 2004-12-28 2011-11-09 オリンパス株式会社 培養観察装置および標本トレー保温装置および蓋
WO2007149525A2 (en) * 2006-06-22 2007-12-27 Manhattan Diagnostics Corp. Petri dish with filter
US8921283B2 (en) * 2006-10-30 2014-12-30 Washington University Method for generating microscopic patterns of protein and other macromolecules
EP2148921B1 (en) * 2007-05-30 2017-07-19 Nikon Corporation Incubation container
US7968062B1 (en) 2007-07-06 2011-06-28 Richard Carle Putnam Drug disposal and verification device
DE102007059199A1 (de) * 2007-12-08 2009-06-10 Cognis Ip Management Gmbh Hautmodell
US8163540B2 (en) * 2008-07-18 2012-04-24 Carlo Acosta Filtered petri dish
MX368123B (es) 2011-11-07 2019-09-19 Rapid Micro Biosystems Inc Cassette para pruebas de esterilidad.
WO2013158666A1 (en) 2012-04-16 2013-10-24 Rapid Micro Biosystems, Inc. Cell culturing device
US9695458B2 (en) 2013-08-27 2017-07-04 Parker-Hannifin Corporation Sample dish and compressed gas microbial test unit
EP3180416A1 (de) * 2014-08-14 2017-06-21 Merck Patent GmbH Petrischale und verfahren zur mikrobiologischen untersuchung von flüssigkeiten mittels membranfiltration
CN107090401A (zh) * 2017-06-09 2017-08-25 天津施特雷生物科技股份有限公司 一种干制一次性无菌微生物培养皿
CN109679833B (zh) * 2019-01-10 2021-10-26 航天神舟生物科技集团有限公司 多因素一体化筛选平板及其制作工具和制作方法
CN109679828B (zh) * 2019-02-22 2020-06-09 胥振国 一种细菌培养用培养皿及使用方法
WO2024080882A1 (en) * 2022-10-10 2024-04-18 Farm Medix Limited Improved microbiological media container

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE839245C (de) * 1949-04-15 1952-05-19 Ewald Dr Med Kanz Verfahren und Einrichtung zur Zuechtung von Kleinlebewesen
US2677646A (en) * 1952-03-22 1954-05-04 Lovell Chemical Company Unit for bacterial analysis
US2954327A (en) * 1955-08-02 1960-09-27 Kanz Ewald Container for nutrient media
US2874091A (en) * 1956-07-23 1959-02-17 Hyland Lab Disposable culturing device
US3073750A (en) * 1959-05-07 1963-01-15 Talb Ind Inc Culture dish
US3055808A (en) * 1959-07-23 1962-09-25 Baltimore Biolog Lab Inc Hermetically sealed petri dish
DE1210129B (de) * 1964-12-03 1966-02-03 St Luke S Hospital Res Foundat Zum Zuechten anaerober Kulturen dienende abdeckbare Flachschale
US3630849A (en) * 1969-04-24 1971-12-28 David B Land Surface micro-organism contamination assays
US3729382A (en) * 1970-12-09 1973-04-24 Becton Dickinson Co Microorganism sampling dish
US3809617A (en) * 1972-11-15 1974-05-07 American Cyanamid Co Device for detecting anticholinesterase materials
SE403382B (sv) * 1974-03-12 1978-08-14 Orion Yhtyme Oy Orion Diagnost Sett vid undersokning av effekten av ett biologiskt aktivt emne pa tillvexten av mikroorganismer som odlas pa ett fast eller gelformigt odlingsmedium
US4030980A (en) * 1975-05-15 1977-06-21 Corning Glass Works Apparatus and method for identification of selected clinical yeast
US4271270A (en) * 1977-10-27 1981-06-02 Lukacsek Patricia A Apparatus for culturing and examining fungi
DE3102571A1 (de) * 1981-01-27 1982-09-16 C.A. Greiner und Söhne GmbH & Co KG, 7440 Nürtingen Petrischale
JPS5863382A (ja) * 1981-10-13 1983-04-15 Terumo Corp 多層微生物培養検査器
US4435508A (en) * 1981-11-20 1984-03-06 Gabridge Michael G Tissue culture vessel
DE3218532A1 (de) * 1982-05-17 1983-11-17 C.A. Greiner und Söhne GmbH & Co KG, 7440 Nürtingen Mit einem naehrboden gefuellte schale zur zuechtung von bakterien und kleinpilzen

Also Published As

Publication number Publication date
AU4591885A (en) 1986-04-17
US4801548A (en) 1989-01-31
JPH0558705B2 (ja) 1993-08-27
DE3565997D1 (en) 1988-12-08
CN85106361A (zh) 1986-04-10
KR860003345A (ko) 1986-05-23
JPS6192561A (ja) 1986-05-10
EP0181075A1 (en) 1986-05-14
AU567225B2 (en) 1987-11-12
CA1252375A (en) 1989-04-11
KR890003945B1 (ko) 1989-10-13
CN85106361B (zh) 1988-01-20
US4775628A (en) 1988-10-04

Similar Documents

Publication Publication Date Title
EP0181075B1 (en) Petri dish for cultivating bacteria and a method of testing drug susceptibility
US3826717A (en) Quantitative antibiotic test container
US4090920A (en) Disposable antibiotic susceptability test package
US4153512A (en) Storage stable antibiotic susceptibility test kit and method of testing
US3107204A (en) Microbiological testing method and structure therefor
US5817510A (en) Device and method for evaluating microorganisms
US3728228A (en) Device for indication of bacterial sensitivity to antibiotics
US2904474A (en) Process and means for carrying out bacteriological operations
CA1290273C (en) Apparatus and methods for microorganism culture and testing
US4385115A (en) Diagnostics testing devices and processes
JPH0315379A (ja) 微生物乾燥培地
IL49468A (en) The container is divided into compartments for test samples
CA2283753C (en) Micropathological patient replica based on unadulterated whole blood
US6632661B2 (en) Self-spreading microbiological culture device
US3902972A (en) Modified petri dish for automatic inoculation
US6291202B1 (en) Disc assay device with inoculation pad and methods of use
US6284531B1 (en) Multi-compartment device for cultivating microorganisms
WO1996019565A1 (fr) Dispositif pour essais chimiques et microbiologiques
US4766063A (en) Process and device for detecting the activity of a substance on a micro-organism or on a mixture of micro-organisms
JPH0678747A (ja) 複数の微生物学的試験を実行するための装置
US2954327A (en) Container for nutrient media
CN1249217C (zh) 细胞培养方法和装置
US3726795A (en) Filtering unit for medical liquids
US4247634A (en) Culture cup and method for sampling and microbial-count determination
CA2082634A1 (en) Multi-nutrient growth culturing system and a method of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI

17P Request for examination filed

Effective date: 19860726

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KOBAYASHI PHARMACEUTICAL CO. LTD.

17Q First examination report despatched

Effective date: 19870626

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

ITF It: translation for a ep patent filed
AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH DE FR GB IT LI

REF Corresponds to:

Ref document number: 3565997

Country of ref document: DE

Date of ref document: 19881208

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19910808

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19910917

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19910920

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19910923

Year of fee payment: 7

ITTA It: last paid annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19920923

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19920930

Ref country code: CH

Effective date: 19920930

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19920923

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19930528

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19930602

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST